Twice-a-day treatment in the radiotherapeutic management of malignant mixed tumor of the parotid gland: A case report.
A patient with a 2,300 gm malignant mixed tumor of the parotid gland had recurrence 19 days post surgery. The recurrent mass failed to respond to daily fractions of 200 rad conventional irradiation four times per week and actually increased in size. A superfractionation scheme was substituted, employing twice-a-day 200 rad at 4-5½ hours intervals three times a week for 2½ weeks. At the completion of treatment, there was a 50 percent regression of the recurrent tumor mass and a 100 percent regression two weeks post irradiation. A protocol using a twice-a-day treatment is discussed.
D008949:Adenoma, Pleomorphic / Q000473:pathology / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010307:Parotid Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D011879:Radiotherapy Dosage